Healthcare provider profile · identity verified

Jeevan S. Daniels, DO

Family Practice · ANAHEIM, CA · NPI 1467529313

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	740	309
Amlodipine Besylate	Amlodipine Besylate	356	148
Rosuvastatin Calcium	Rosuvastatin Calcium	305	127
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	295	110
Lisinopril	Lisinopril	282	120
Losartan Potassium	Losartan Potassium	256	122
Levothyroxine Sodium	Levothyroxine Sodium	245	101
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	228	87
Simvastatin	Simvastatin	217	77
Atenolol	Atenolol	195	71
Metformin Hcl	Metformin Hcl	166	68
Potassium Chloride	Potassium Chloride	153	64
Gabapentin	Gabapentin	142	58
Terazosin Hcl	Terazosin Hcl	137	43
Meloxicam	Meloxicam	135	54
Metformin Hcl Er	Metformin Hcl	134	55
Metoprolol Tartrate	Metoprolol Tartrate	129	52
Albuterol Sulfate Hfa	Albuterol Sulfate	122	74
Tamsulosin Hcl	Tamsulosin Hcl	118	51
Pantoprazole Sodium	Pantoprazole Sodium	111	44
Alendronate Sodium	Alendronate Sodium	110	48
Allopurinol	Allopurinol	110	41
Hydrochlorothiazide	Hydrochlorothiazide	109	51
Omeprazole	Omeprazole	105	55
Glipizide	Glipizide	102	39
Furosemide	Furosemide	96	34
Trazodone Hcl	Trazodone Hcl	90	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	89	23
Jardiance	Empagliflozin	82	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	31
Azelastine Hcl	Azelastine Hcl	78	30
Ozempic	Semaglutide	71	17
Pradaxa	Dabigatran Etexilate Mesylate	71	30
Tramadol Hcl	Tramadol Hcl	71	28
Ibuprofen	Ibuprofen	65	28
Clopidogrel	Clopidogrel Bisulfate	54	21
Fluoxetine Hcl	Fluoxetine Hcl	52	22
Bisoprolol Fumarate	Bisoprolol Fumarate	49	16
Triamcinolone Acetonide	Triamcinolone Acetonide	49	24
Sertraline Hcl	Sertraline Hcl	47	17
Carvedilol	Carvedilol	46	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	44	23
Donepezil Hcl	Donepezil Hcl	43	15
Ezetimibe	Ezetimibe	42	17
Pioglitazone Hcl	Pioglitazone Hcl	40	13
Bupropion Hcl Sr	Bupropion Hcl	39	19
Pravastatin Sodium	Pravastatin Sodium	38	16
Alvesco	Ciclesonide	37	11
Fluticasone Propionate	Fluticasone Propionate	37	15
Glipizide-Metformin	Glipizide/Metformin Hcl	37	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	37	15
Victoza 2-Pak	Liraglutide	37	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	37	17
Naltrexone Hcl	Naltrexone Hcl	35	18
Breyna	Budesonide/Formoterol Fumarate	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	18
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	13
Eliquis	Apixaban	32	14
Famotidine	Famotidine	32	17
Finasteride	Finasteride	31	15
Humulin N	Insulin Nph Human Isophane	30	13
Hydralazine Hcl	Hydralazine Hcl	30	11
Lactulose	Lactulose	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Testosterone	Testosterone	26	suppressed
Liraglutide	Liraglutide	25	suppressed
Acyclovir	Acyclovir	24	16
Amoxicillin	Amoxicillin	24	17
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Prednisone	Prednisone	23	23
Spironolactone	Spironolactone	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Digoxin	Digoxin	22	suppressed
Morphine Sulfate	Morphine Sulfate	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	21	suppressed
Hydrocortisone	Hydrocortisone	21	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Cefadroxil	Cefadroxil	20	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Cephalexin	Cephalexin	19	19
Lorazepam	Lorazepam	19	13
Diazepam	Diazepam	18	suppressed
Humalog	Insulin Lispro	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Estradiol	Estradiol	15	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	15	15
Humulin R	Insulin Regular, Human	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nystatin	Nystatin	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Metoprolol Succinate	Metoprolol Succinate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Riluzole	Riluzole	13	suppressed
Topiramate	Topiramate	13	suppressed
Alprazolam	Alprazolam	12	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Colchicine	Colchicine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error